• Explore /
  • Poster
  • / Radiological markers of treatment responsiveness in patients (pts) with metastatic pancreatic ductal adenocarcinomas (mPDAC) receiving systemic chemotherapy.

Radiological markers of treatment responsiveness in patients (pts) with metastatic pancreatic ductal adenocarcinomas (mPDAC) receiving systemic chemotherapy.

Abstract Poster

Authors

null

Peter Yong Soo Park

Banner MD Anderson Cancer Center, Gilbert, AZ

Peter Yong Soo Park , Kenyon Verner McAferty , Michael Ahmadi , Kewei Chen , John Chang , Tomislav Dragovich , Madappa N. Kundranda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 403)

DOI

10.1200/jco.2016.34.4_suppl.403

Abstract #

403

Poster Bd #

K19

Abstract Disclosures

Similar Posters

First Author: Erica S Tsang

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Clinical impact of <em>KRAS</em> mutations in metastatic pancreatic ductal adenocarcinoma (PDAC).

Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC).

First Author: Carter Norton

First Author: Ravi Kumar Paluri

First Author: Zev A. Wainberg